During the past decade, Waterbury Pulmonary Associates conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 7 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Waterbury Pulmonary Associates" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "bioAffinity Technologies Inc." with 2 trials sponsored, "Bellerophon Pulse Technologies" with 1 trials sponsored, "Daiichi Sankyo, Inc." with 1 trials sponsored and "MedImmune LLC" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Waterbury Pulmonary Associates" #1 collaborator was "Sanofi" with 1 trials as a collaborator, "University of Illinois at Chicago" with 1 trials as a collaborator and "VA Puget Sound Health Care System" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Waterbury Pulmonary Associates" are "Asthma" (7 trials), "Chronic Obstructive Pulmonary Disease (COPD)" (2 trials), "Lung Cancer" (2 trials), "Cachexia" (1 trials) and "Chronic Obstructive Pulmonary Disease" (1 trials). Many other conditions were trialed in "Waterbury Pulmonary Associates" in a lesser frequency.

Most popular intervention types in "Waterbury Pulmonary Associates" are "Drug" (8 trials), "Biological" (2 trials), "Other" (2 trials), "Behavioral" (1 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Arformoterol tartrate inhalation solution" (1 trials), "DUPIXENT®" (1 trials), "FP" (1 trials) and "IMA-638" (1 trials). Other intervention names were less common.

The vast majority of trials in "Waterbury Pulmonary Associates" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Waterbury Pulmonary Associates". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Waterbury Pulmonary Associates, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Waterbury Pulmonary Associates, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".

Waterbury Pulmonary Associates has several departments that took part in Clinical trials: "Waterbury Pulmonary Research" - 2 trials